Legal Updates
Merck to Pay $8 Million for Fosamax injury
Saturday, June 26, 2010
Fosamax, a bisphosphonate drug manufactured by Merck; gained FDA approval on September 29, 1995. It generated three billion dollars of revenue for Merck in 2006. In 2004, the FDA and Merck, as well as the manufacturers of other bisphosphonates, updated the drugs labels to warn about osteonecrosis of the jawbone.…
Fosamax Case Set For Trial
Monday, February 01, 2010
On January 29, 2010, a Manhattan federal judge refused to reject a lawsuit alleging that Merck & Co Inc's osteoporosis drug Fosamax caused jaw damage to an Indiana woman during the nearly eight years she took the pill. According to a Reuters report, Merck submitted a motion seeking to dismiss…
Judge Rules Fosamax Cases Cannot be Dismissed
Wednesday, September 09, 2009
On September 9, 2009, a Manhattan federal judge rejected Merck & Co’s effort to dismiss twenty four cases alleging that its Fosamax drug treatment for osteoporosis causes jaw damage. U.S. District Judge John Keenan ruled that the plaintiffs could introduce testimony by two doctors to show that the drug can…
Fosamax Trail Begins for First Plaintiff
Wednesday, August 12, 2009
On August 11, 2009, the first of many lawsuits brought by patients who claim they suffered jaw damage from Fosamax began. An estiamted 1280 plaintiff groups, involving almost 900 cases, have alleged jaw problems due to Fosamax. U.S. District Judge John Keenan of Manhattan Federal Court heard arguments from attorneys…
Osteoporosis Drugs Cause Jaw Problems
Friday, January 02, 2009
A new study released on January 1, 2008 suggests that patients prescribed oral osteoporosis drugs may be at a much higher risk of developing Osteonecrosis of the jaw (ONJ). Past reports indicated that the risk of developing Osteonecrosis of the jaw (ONJ) from bisphosphonates in pill form were "negligible," although…
Osteoporosis Drugs Linked to Esophageal Cancer
Thursday, January 01, 2009
On December 31, 2008, FDA officials announced that Merck's popular osteoporosis drug Fosamax and other similar drugs may carry a risk for esophageal cancer. Diane Wysowski of the FDA's division of drug risk assessment said researchers should check into potential links between so called bisphosphonate drugs and cancer. In a…
